Stay updated on Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    1%
    Check dated 2025-07-04T03:51:31.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The timeline for the modernization of the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025, with the version revision changing from v2.16.2 to v2.16.4.
    Difference
    2%
    Check dated 2025-06-19T19:34:55.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:06:23.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T05:51:39.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:50:01.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed study information regarding the safety and clinical activity of nivolumab and relatlimab in treating MSS colorectal cancer, as well as the deletion of specific inclusion and exclusion criteria for participants. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    24%
    Check dated 2025-04-16T01:45:23.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.